- Reported net sales totaled $1.4
billion.
- GAAP earnings decreased to $0.43 per
diluted share.
- Adjusted earnings1
declined to $0.51 per diluted share.
- Company revises fiscal 2018 outlook
and now expects adjusted earnings1 to be in the range
of $2.00 to $2.10 per diluted share.
Patterson Companies, Inc. (Nasdaq: PDCO) today reported
consolidated net sales of $1.4 billion (see attached Sales Summary
for further details) in its fiscal second quarter ended October 28,
2017, a decline of 2.3 percent compared to the same period last
year. Adjusting for the effects of currency translation, sales
declined 2.8 percent, including a negative impact from recent
hurricanes of approximately 60 basis points.
Reported net income for the second quarter of fiscal year 2018
was $40.2 million, or $0.43 per diluted share, compared to $45.8
million, or $0.48 per diluted share, in last year’s fiscal second
quarter. Adjusted net income1, which excludes certain non-recurring
items and deal amortization costs, totaled $47.6 million for the
second quarter of fiscal 2018, down 11.1 percent from $53.5 million
in the same quarter last year. Adjusted net income1 includes
the previously disclosed pre-tax step-up in enterprise resource
planning expenses, which for the quarter was approximately $4
million. Adjusted earnings1 per diluted share totaled $0.51 in the
second quarter, down 8.9 percent year-over-year, including the
negative impact from recent hurricanes of approximately $0.01 per
diluted share.
“Our performance during the 2018 second quarter reflected the
impact of several strategic initiatives to position the company for
growth, varied end-market conditions and the impact of hurricanes
on sales volumes,” said James Wiltz, who served as interim
president and chief executive officer during the quarter. “We have
completed the U.S. rollout of our enterprise resource planning
initiative – a very important milestone – and we will continue to
refine this new operational platform. Our Animal Health segment
results benefited from sales and marketing execution and favorable
end-market fundamentals. Performance in our Dental segment
reflected the near-term impact from our strategic initiatives as
well as the stable end-market conditions. As previously announced,
effective November 20, 2017, Mark Walchirk has joined us as our
president and chief executive officer. On behalf of the board of
directors, we are excited to welcome Mark to Patterson, and we look
forward to his new leadership.”
Patterson Dental
Reported net sales in our Dental segment for the second quarter,
which represented approximately 40 percent of total company sales,
were $553.6 million, down 8.0 percent from the same quarter last
year. Sales declined 8.4 percent on a constant currency basis
compared to the fiscal 2017 second quarter, including an estimated
90 basis point negative impact from recent hurricanes. On that same
basis, year-over-year sales by category were as follows:
- Equipment sales declined 17.7 percent,
primarily due to a decrease in sales of CEREC and digital
technology products.
- Consumable dental supplies decreased
4.4 percent.
- Other services and products, primarily
composed of technical service, parts and labor, software support
services and office supplies increased 0.6 percent.
“While we expanded our technology offerings and worked toward
improving our sales force effectiveness in the Dental segment
during the second quarter, our results were weaker than
anticipated,” continued Wiltz, “We continue to believe our decision
to transition to an expanded digital technology portfolio will
allow Patterson to better serve a wider range of clinical
environments, and we are working to increase sales force headcount
and effectiveness.”
Patterson Animal Health
Reported net sales in our Animal Health segment for the second
quarter of fiscal 2018, which comprised approximately 60 percent of
the company’s total sales, were $823.6 million, up 2.0 percent from
last year’s second quarter. Sales increased 1.4 percent on a
constant currency basis from the fiscal 2017 second quarter,
including an estimated negative impact of 30 basis points from
recent hurricanes. On that same basis, year-over-year sales by
category were as follows:
- Companion animal sales declined 1.4
percent. After normalizing for changes in selling relationships,
companion animal sales rose approximately 3.2 percent.
- Production animal sales increased 4.2
percent, reflecting strong performance across all species.
Said Wiltz, “In our Animal Heath segment, we are pleased with
our sales execution, market share gains and margin improvement. We
believe we outperformed the market during the second quarter, and
we achieved positive topline growth across all species with
especially strong performance in our swine business. End-market
fundamentals in both the companion animal and production animal
markets remain solid, and we are encouraged by the near-term
prospects in our Animal Health business.”
Share Repurchases and Dividends
In the second quarter of fiscal 2018, Patterson repurchased
approximately 1.0 million shares of its outstanding common stock,
with a value of $36.5 million, leaving approximately 11.9 million
shares for repurchase under the current authorization, which
expires in March 2018. The company also paid $24.8 million in cash
dividends to shareholders in the second quarter of fiscal 2018. For
the first six months of fiscal 2018, the company has returned a
total of $124 million to shareholders in the form of share
repurchases and dividends.
Year-to-Date Results1
Consolidated sales for the first six months of fiscal 2018
totaled $2.7 billion, a 2.2 percent year-over-year decrease.
Reported net income was $71.1 million, or $0.76 per
diluted share, compared to $84.7 million,
or $0.88 per diluted share in last year's period.
Adjusted net income1, which excludes certain deal
amortization costs and integration and business restructuring
costs, totaled $89.0 million, or $0.95 per diluted
share, compared to adjusted net income of $102.3 million,
or $1.06 per diluted share, in the year-ago period.
Fiscal 2018 Guidance
Patterson today revised its fiscal 2018 earnings guidance, which
is provided on both a GAAP and non-GAAP adjusted1 basis:
- GAAP earnings are now expected to be in
the range of $1.67 to $1.77 per diluted share.
- Non-GAAP adjusted earnings1 for fiscal
2018 are now expected to be in the range of $2.00 to $2.10 per
diluted share.
- Our non-GAAP adjusted earnings1
guidance excludes the after-tax impact of:
- Deal amortization expense of
approximately $25.3 million ($0.27 per diluted share)
- Integration and business restructuring
expenses of approximately $5.3 million ($0.06 per diluted
share)
Our guidance is for current continuing operations as well as
completed or previously announced acquisitions and does not include
the impact of potential future acquisitions or similar
transactions, if any, or impairments and material restructurings
beyond those previously publicly disclosed. Our guidance assumes
North American and international market conditions similar to those
experienced in the first half of fiscal 2018.
1Non-GAAP Financial Measures
The Reconciliation of GAAP to non-GAAP Measures table appearing
behind the accompanying financial information is provided to adjust
reported GAAP measures, namely earnings, net income and earnings
per diluted share, for the impact of transaction related costs,
deal amortization expenses and integration and business
restructuring expenses, along with the related tax effects of these
items.
Management believes that these non-GAAP measures may provide a
helpful representation of the company's second quarter and
full-year performance, and enable comparison of financial results
between periods where certain items may vary independent of
business performance. These non-GAAP financial measures are
presented solely for informational and comparative purposes and
should not be regarded as a replacement for corresponding,
similarly captioned, GAAP measures.
In addition, the term constant currency used in this release
represents net sales adjusted to exclude foreign currency impacts.
Foreign currency impact represents the difference in results that
is attributable to fluctuations in currency exchange rates the
company uses to convert results for all foreign entities where the
functional currency is not the U.S. dollar. The company
calculates the impact as the difference between the current period
results translated using the current period currency exchange rates
and using the comparable prior period's currency exchange rates.
The company believes the disclosure of net sales changes in
constant currency provides useful supplementary information to
investors in light of significant fluctuations in currency
rates.
Second-Quarter Conference Call and Replay
Patterson’s second-quarter earnings conference call will start
at 10 a.m. Eastern today. Investors can listen to a live webcast of
the conference call at www.pattersoncompanies.com. The conference
call will be archived on Patterson’s website. A replay of the
fiscal 2018 second-quarter conference call can be heard for one
week at 800-585-8367 and by providing the Conference ID 6697939
when prompted.
About Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving
the dental and animal health markets.
Dental Market
Patterson's Dental segment provides a virtually complete range
of consumable dental products, equipment and software, turnkey
digital solutions and value-added services to dentists and dental
laboratories throughout North America.
Animal Health Market
Patterson's Animal Health segment is a leading distributor of
products, services and technologies to both the production and
companion animal health markets in North America and the U.K.
This press release contains certain forward-looking statements,
as defined in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are information of a non-historical
nature and are subject to risks and uncertainties that are beyond
Patterson's ability to control. Forward-looking statements
generally can be identified by words such as "believes," "expects,"
"anticipates," "foresees," "forecasts," "estimates" or other words
or phrases of similar import. It is uncertain whether any of the
events anticipated by the forward-looking statements will transpire
or occur, or if any of them do, what impact they will have on the
results of operations and financial condition of Patterson or the
price of Patterson stock. These forward-looking statements involve
certain risks and uncertainties that could cause actual results to
differ materially from those indicated in such forward-looking
statements. Such risks and uncertainties include, without
limitation, operations disruptions attributable to our enterprise
resource planning system implementation; our ability to attract or
retain qualified sales representatives and service technicians who
relate directly with our customers; the reduction, modification,
cancellation or delay of purchases of innovative, high-margin
equipment; material changes in our purchasing relationships with
suppliers; changes in general market and economics conditions; and
the other risks and important factors contained and identified in
Patterson's filings with the Securities and Exchange Commission,
such as its Quarterly Reports on Form 10-Q and Annual Reports on
Form 10-K, any of which could cause actual results to differ
materially from the forward-looking statements. Any forward-looking
statement in this press release speaks only as of the date on which
it is made. Except to the extent required under the federal
securities laws, Patterson does not intend to update or revise the
forward-looking statements.
PATTERSON COMPANIES, INC. CONDENSED CONSOLIDATED
STATEMENTS OF INCOME (In thousands, except per share
amounts) (Unaudited)
Three Months Ended Six Months
Ended October 28, October 29, October 28,
October 29, 2017 2016 2017 2016
Net sales $ 1,385,737 $ 1,418,241 $ 2,689,852 $ 2,750,677
Gross profit 315,743 318,960 614,791 636,138
Operating expenses 243,984 239,157
486,199 490,919 Operating income
71,759 79,803 128,592 145,219 Other income (expense): Other
income, net 1,160 1,622 2,672 3,986 Interest expense (11,468
) (10,097 ) (22,671 ) (20,259 ) Income
before taxes 61,451 71,328 108,593 128,946 Income tax
expense 21,207 25,572 37,502 44,284 Net
income $ 40,244 $ 45,756 $ 71,091 $ 84,662
Earnings per share: Basic $ 0.43 $ 0.48
$ 0.76 $ 0.89 Diluted $ 0.43 $ 0.48 $
0.76 $ 0.88 Weighted average shares: Basic
92,722 95,290 93,037 95,510 Diluted 93,351 95,904 93,683 96,138
Dividends declared per common share $ 0.26 $ 0.24 $ 0.52 $
0.48
PATTERSON COMPANIES, INC. CONDENSED
CONSOLIDATED BALANCE SHEETS (In thousands)
October 28, April 29, 2017
2017 (Unaudited) ASSETS Current assets: Cash
and cash equivalents $ 101,456 $ 94,959 Receivables 849,205 884,803
Inventory 796,369 711,903 Prepaid expenses and other current assets
96,578 111,928 Total current assets 1,843,608
1,803,593 Property and equipment, net 286,715 298,452 Goodwill and
other intangible assets 1,220,865 1,238,983 Long-term receivables,
net and other 177,291 166,885 Total assets $
3,528,479 $ 3,507,913
LIABILITIES AND STOCKHOLDERS'
EQUITY Current liabilities: Accounts payable $ 634,594 $
616,859 Other accrued liabilities 209,283 213,318 Current
maturities of long-term debt 14,754 14,754 Borrowings on revolving
credit 92,000 59,000 Total current liabilities
950,631 903,931 Long-term debt 991,232 998,272 Other non-current
liabilities 219,676 211,277 Total liabilities
2,161,539 2,113,480 Stockholders' equity 1,366,940
1,394,433 Total liabilities and stockholders' equity $ 3,528,479 $
3,507,913
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In
thousands) (Unaudited)
Six Months Ended
October 28,
October 29,
2017 2016
Operating activities:
Net income $ 71,091 $ 84,662 Adjustments to reconcile net income to
net cash provided by (used in) operating activities: Depreciation
and amortization 41,833 42,007 Non-cash employee compensation
16,635 14,693 Change in assets and liabilities, net of acquired
(52,451 ) (196,668 ) Net cash provided by (used in)
operating activities 77,108 (55,306 )
Investing activities:
Additions to property and equipment (16,431 ) (29,377 ) Collection
of deferred purchase price receivables 24,581 26,210 Other
investing activities 11,626 (3,095 ) Net cash
provided by (used in) investing activities 19,776 (6,262 )
Financing activities:
Dividends paid (49,969 ) (47,655 ) Repurchases of common stock
(71,254 ) (50,000 ) Retirement of long-term debt (7,377 ) (8,250 )
Draw on revolver 33,000 143,000 Other financing activities
3,561 974 Net cash provided by (used in)
financing activities (92,039 ) 38,069 Effect of exchange rate
changes on cash 1,652 (3,567 ) Net change in
cash and cash equivalents $ 6,497 $ (27,066 )
PATTERSON COMPANIES, INC. SALES SUMMARY (Dollars
in thousands) (Unaudited)
Total Foreign
October 28,
October 29,
Sales Exchange
Internal
2017
2016
Growth Impact
Growth
Three Months
Ended
Consolidated net sales Consumable $ 1,116,091 $ 1,112,232
0.3 % 0.5 % (0.2 ) % Equipment and software 181,337 217,194 (16.5 )
0.4 (16.9 ) Other 88,309 88,815 (0.6 ) 0.3
(0.9 ) Total $ 1,385,737 $ 1,418,241 (2.3 ) %
0.5 % (2.8 ) % Dental Consumable $ 311,217 $ 324,237
(4.0 ) % 0.4 % (4.4 ) % Equipment and software 169,513 205,062
(17.3 ) 0.4 (17.7 ) Other 72,900 72,254 0.9
0.3 0.6 Total $ 553,630 $
601,553 (8.0 ) % 0.4 % (8.4 ) % Animal Health
Consumable $ 804,874 $ 787,995 2.1 % 0.6 % 1.5 % Equipment and
software 11,824 12,132 (2.5 ) - (2.5 ) Other 6,885
7,019 (1.9 ) 0.9 (2.8 ) Total $ 823,583
$ 807,146 2.0 % 0.6 % 1.4 % Corporate
Other $ 8,524 $ 9,542 (10.7 ) % - % (10.7 ) % Total $ 8,524
$ 9,542 (10.7 ) % - % (10.7 ) %
Six Months
Ended
Consolidated net sales Consumable $ 2,196,196 $ 2,188,453
0.4 % (0.3 ) % 0.7 % Equipment and software 318,286 378,140 (15.8 )
0.1 (15.9 ) Other 175,370 184,084 (4.7 ) (0.1
) (4.6 ) Total $ 2,689,852 $ 2,750,677 (2.2 ) % (0.2
) % (2.0 ) % Dental Consumable $ 631,395 $ 657,185 (3.9 ) %
0.1 % (4.0 ) % Equipment and software 297,376 355,944 (16.5 ) 0.2
(16.7 ) Other 143,666 143,439 0.2 0.1
0.1 Total $ 1,072,437 $ 1,156,568 (7.3
) % 0.1 % (7.4 ) % Animal Health Consumable $
1,564,801 $ 1,531,268 2.2 % (0.5 ) % 2.7 % Equipment and software
20,910 22,196 (5.8 ) - (5.8 ) Other 14,008 16,313
(14.1 ) (1.8 ) (12.3 ) Total $ 1,599,719 $
1,569,777 1.9 % (0.5 ) % 2.4 % Corporate Other
$ 17,696 $ 24,332 (27.3 ) % - % (27.3 ) % Total $ 17,696 $
24,332 (27.3 ) % - % (27.3 ) %
PATTERSON
COMPANIES, INC. OPERATING INCOME BY SEGMENT (In
thousands) (Unaudited)
Three Months Ended Six Months
Ended October 28, October 29, October 28,
October 29, 2017 2016 2017 2016
Operating income (loss) Dental $ 65,207 $ 77,043 $ 124,726 $
137,338 Animal Health 23,217 21,854 39,893 36,683 Corporate
(16,665 ) (19,094 ) (36,027 ) (28,802 ) Total
$ 71,759 $ 79,803 $ 128,592 $ 145,219
PATTERSON COMPANIES, INC. RECONCILIATION OF
GAAP TO NON-GAAP MEASURES (Dollars in thousands, except per
share amounts) (Unaudited)
For the three months ended October 28,
2017
GAAP
Transaction-related
costs
Deal amortization
Integration
andbusinessrestructuringexpenses
Non-GAAP
Operating income $ 71,759 $ — $ 9,660 $ 1,688 $ 83,107 Other
expense, net (10,308 ) — — —
(10,308 ) Income before taxes 61,451 — 9,660 1,688 72,799 Income
tax expense 21,207 — 3,346 638
25,191 Net income $ 40,244 $ — $ 6,314 $ 1,050
$ 47,608 Diluted earnings
per share* $ 0.43 $ — $ 0.07 $ 0.01 $ 0.51
Consolidated operating income as a % of sales 5.2 % 6.0 % Effective
tax rate 34.5 % 34.6 %
For the three months ended October 29,
2016
GAAP
Transaction-related
costs
Deal amortization
Integration
andbusinessrestructuringexpenses
Non-GAAP
Operating income $ 79,803 $ 896 $ 10,247 $ 804 $ 91,750 Other
expense, net (8,475 ) — — —
(8,475 ) Income before taxes 71,328 896 10,247 804 83,275 Income
tax expense 25,572 338 3,537 304
29,751 Net income $ 45,756 $ 558 $ 6,710 $ 500
$ 53,524 Diluted earnings
per share* $ 0.48 $ 0.01 $ 0.07 $ 0.01 $ 0.56
Consolidated operating income as a % of sales 5.6 % 6.5 % Effective
tax rate 35.9 % 35.7 %
For the six months ended October
28, 2017 GAAP
Transaction-related
costs
Deal amortization
Integration
andbusinessrestructuringexpenses
Non-GAAP Operating income $ 128,592 $ — $ 19,290 $ 8,594 $
156,476 Other expense, net (19,999 ) — —
— (19,999 ) Income before taxes 108,593 — 19,290
8,594 136,477 Income tax expense 37,502 —
6,691 3,249 47,442 Net income $ 71,091
$ — $ 12,599 $ 5,345 $ 89,035
Diluted earnings per share* $ 0.76 $ — $ 0.13
$ 0.06 $ 0.95 Consolidated operating income as a % of
sales 4.8 % 5.8 % Effective tax rate 34.5 % 34.8 %
For
the six months ended October 29, 2016 GAAP
Transaction-related
costs
Deal amortization
Integration
andbusinessrestructuringexpenses
Non-GAAP Operating income $ 145,219 $ 1,243 $ 20,261 $ 5,679
$ 172,402 Other expense, net (16,273 ) — —
— (16,273 ) Income before taxes 128,946 1,243 20,261
5,679 156,129 Income tax expense 44,284 469
6,914 2,147 53,814 Net income $ 84,662
$ 774 $ 13,347 $ 3,532 $ 102,315
Diluted earnings per share* $ 0.88 $ 0.01 $
0.14 $ 0.04 $ 1.06 Consolidated operating income as a
% of sales 5.3 % 6.3 % Effective tax rate 34.3 % 34.5 % *
May not sum due to rounding
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171121005301/en/
Patterson Companies, Inc.Ann B. Gugino, 651-686-1600Executive
Vice President & CFOorJohn M. Wright, 651-686-1364Vice
President, Investor Relations
Patterson Companies (NASDAQ:PDCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Patterson Companies (NASDAQ:PDCO)
Historical Stock Chart
From Apr 2023 to Apr 2024